When James Choate-Deeds was diagnosed with prostate cancer, he joined a clinical trial for robotic-assisted surgery ...

Lt. Col. Ronald “RJ” Caras, a urologist at Madigan Army Medical Center, has been named the American Urological Association’s ...

Driven by a growing patient population, rapid adoption of minimally invasive and robotic technologies, increased use of diagnostic-guided focal therapies, and the ongoing dominance of proven ...

Have you been struggling with frequent urination, interrupted sleep, or suffering from erectile dysfunction, and wondered if ...

•Lagos hospital makes breakthrough in prostate surgeryBy Doris ObinnaFor decades, prostate disease has remained one of the most feared diagnoses among Nigerian men, often associated with late ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

A novel cooled laser focal therapy device demonstrates 84% treatment success for localized prostate cancer at 3 months, with only 12% reporting erectile dysfunction and minimal impact on urinary ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...

Laser therapy reduces bleeding and post-operative pain compared to osseous surgery by cauterizing nerve endings and blood vessels. The procedure targets diseased tissue specifically, leaving healthy ...

Thulium fiber laser enucleation of the prostate (ThuFLEP) is a minimally invasive treatment for benign prostatic hyperplasia (BPH). Some patients undergoing ThuFLEP are later treated with external ...

The most common surgery for prostate cancer is a radical prostatectomy. This surgery involves taking out the entire prostate gland, some lymph nodes and other nearby tissue, like the seminal vesicles ...

A 64-year-old long-distance runner, Todd Elworthy was alarmed and confused when his routine prostate specific antigen (PSA) test was elevated in 2023, and a biopsy came back positive for prostate ...